News & Updates
Showing Dermatology articles
Showing
Show Multimedia Only

Lebrikizumab efficacy in atopic dermatitis maintained at 1 year
12 Oct 2022
byRoshini Claire Anthony
Maintenance lebrikizumab monotherapy appears to improve outcomes in patients with moderate-to-severe atopic dermatitis (AD), according to results of the phase III ADvocate1 and ADvocate2 trials.
12 Oct 2022

Subcutaneous, sublingual immunotherapy to aeroallergens helps with atopic dermatitis
08 Oct 2022
The use of sublingual (SLIT) or subcutaneous (SCIT) immunotherapy against aeroallergens can help improve disease severity and quality of life (QoL) among patients with atopic dermatitis (AD), reports a recent meta-analysis.
08 Oct 2022

Deucravacitinib bestows benefits in Asian patients with plaque psoriasis
04 Oct 2022
byRoshini Claire Anthony
The benefit of deucravacitinib in moderate to severe plaque psoriasis was demonstrated in a population of Asian patients, according to results of the phase III POETYK PSO-3 trial.
04 Oct 2022





